Watermark Market Neutral Trust A is an Managed Funds investment product that is benchmarked against Credit Suisse AllHedge Long/Short Equity Index and sits inside the Alternatives - Market Neutral Index. Think of a benchmark as a standard where investment performance can be measured. Typically, market indices like the ASX200 and market-segment stock indexes are used for this purpose. The Watermark Market Neutral Trust A has Assets Under Management of 36.00 M with a management fee of 1.53%, a performance fee of 0 and a buy/sell spread fee of 0.6%.
The event-driven strategy aims to exploit pricing inefficiencies around corporate activity, in particular M&A events. The month of September saw world equity markets plummet with the Australian Share market (ASX 200) falling -7.3%, and the MSCI Asia Pacific -12.4%. Against this backdrop the Fund’s net performance came in at -8.8 % for the month of September and the portfolio was not immune to withstand the pressure on general M&A deal spread widening risk that drove market-to-market losses, existing M&A deals falling over, temporary Beta dislocation against our hedges (particularly on the short side) as well as some of our direction Alpha trades falling by more than the market. The negative market sentiment in the USA continues to spill around our region, as fears surrounding the rise in inflationary pressures, hawkish commentary from the US Federal Reserve back, saw the US equity markets experience their worst September month since 2008. For the Calendar Year the S&P 500 is now -25%. We are disappointed that for this month the Fund underdelivered on the promise of delivering Alpha returns, but it was owing to very unusual black swan events particularly in some of our M&A positions that experienced 7 deal breaks during the month.
Overall Fund gross exposure ended at 214% vs 219% the previous month, with the Event (M&A Risk Arb) bucket at 87%, the Relative Value bucket at 106% and the directional Alpha at 20%. The M&A bucket, which include unannounced M&A deal transactions, Stake building exercises as well as Capital Return trades contributed -2.6% towards overall performance. High profile deal breaks in Australia were Ramsay Healthcare (RHC AU) as well as Link Group (LNK AU). We have kept a small position in RHC as rumours emerged that the bidding entity KKR consortium had called off their takeover talks. However, KKR continued to commit to the cash/scrip proposal until on September 26th both RHC and KKR agreed to mutually terminate discussions. As for LNK, one of the last remaining condition, namely the FCA approval, was not fulfilled as the FCA proposed a A$516m redress payment for legacy issues. As LNK did not make any provisions in their balance sheet, and was completely ignored by market participants, this material payment effectively killed any chance that the deal with Dye and Durham would complete.
Product Snapshot
Performance Review
Product Overview
Peer Comparison
Product Details